This project will try to identify whether exosomes are targeting a specific type of cell to give their messages to and attempt to hijack this process to be able to deliver anti-cancer agents specifically to these sites. This will allow us to develop a selective treatment option for men with metastatic prostate cancer that could potentially lead to a reduction in the number of deaths associated with this disease.
Mr Joshua Brzozowski, Dr Judith Weidenhofer, Dr Kathryn Skelding